GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Marketable Securities

ReproCELLorp (TSE:4978) Marketable Securities : 円2,121 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is ReproCELLorp Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ReproCELLorp's Marketable Securities for the quarter that ended in Sep. 2024 was 円2,121 Mil.

ReproCELLorp's annual Marketable Securities increased from Mar. 2022 (円2,000 Mil) to Mar. 2023 (円4,465 Mil) but then declined from Mar. 2023 (円4,465 Mil) to Mar. 2024 (円3,628 Mil).


ReproCELLorp Marketable Securities Historical Data

The historical data trend for ReproCELLorp's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReproCELLorp Marketable Securities Chart

ReproCELLorp Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 600.00 2,000.00 2,000.00 4,464.85 3,627.80

ReproCELLorp Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,987.06 4,003.71 3,627.80 - 2,120.78

ReproCELLorp Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


ReproCELLorp  (TSE:4978) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


ReproCELLorp Marketable Securities Related Terms

Thank you for viewing the detailed overview of ReproCELLorp's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


ReproCELLorp Business Description

Traded in Other Exchanges
N/A
Address
KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.

ReproCELLorp Headlines

No Headlines